SlideShare une entreprise Scribd logo
1  sur  3
5-YEAR SURVIVAL
OF GASTRIC
CANCER PATIENTS
AFTER COMPLETE
GASTRECTOMIES
SIGNIFICANTLY
DEPENDED ON PHASE
TRANSITION “EARLY-
INVASIVE CANCER”,
LYMPH NODE
METASTASES AND CELL
RATIO FACTORS
    Oleg Kshivets
       EP144
   2012 WCC-1864
5-YEAR SURVIVAL OF GASTRIC CANCER
PATIENTS AFTER COMPLETE
GASTRECTOMIES SIGNIFICANTLY
DEPENDED ON PHASE TRANSITION
“EARLY-INVASIVE CANCER”, LYMPH NODE
METASTASES AND CELL RATIO FACTORS
Oleg Kshivets
OBJECTIVE: We examined prognostic factors of gastric cancer (GC)
patients (GCP) (T1-4N0-2M0) after complete (R0) gastrectomies (GE).
        Cox Regression: Variables in the Equation
 Chi2=74.35; df=5;
 P=0.00000;        B     SE     Wald df Sig. Exp(B)

 PT E-I Cancer                                                                              -,340                       ,169                            4,047   1    ,044                                          ,712

 PT N0-N12                                                                                  -,272                       ,046 35,091                             1    ,000                                          ,762

 Monocytes/CC                                                                                      ,384                 ,193                            3,947   1    ,047                                         1,468

 Lymphocytes/CC                                                                             -,098                       ,046                            4,527   1    ,033                                          ,906

 Erythrocytes/CC                                                                                   ,013                 ,021                             ,385   1    ,535                                         1,013
                                                  Cumulative Proportion Surviving (Kaplan-Meier)                                                                                                                          Cumulative Proportion Surviving (Kaplan-Meier)
                                                                                  Complete                   Censored                                                                                                                                     Complete                          Censored
                                                                           P=0.000 by Log-Rank Test                                                                                                                                                P=0.000 by Log-Rank Test

                                   1.0                                                                                                                                                                  1.0
                                   0.9                                                                                                                                                                  0.9                                                                     GCP with N1-2, n=309
                                                                                                                                                                                                                                                                                GCP with N0, n=303
                                                                                                                                                                      Cumulative Proportion Surviving
 Cumulative Proportion Surviving




                                   0.8                                                                                                                                                                  0.8

                                   0.7                                                                                                                                                                  0.7

                                   0.6                                                                                                                                                                  0.6

                                   0.5                                                                                                                                                                  0.5
                                                                                                                             Invasive GCP, n=515
                                   0.4                                                                                       Early GCP, n=97                                                            0.4

                                   0.3                                                                                                                                                                  0.3

                                   0.2                                                                                                                                                                  0.2

                                   0.1                                                                                                                                                                  0.1

                                   0.0                                                                                                                                                                  0.0
                                          0   5       10                          15                    20              25                         30     35    40                                            0     5         10                          15                         20                25   30   35   40

                                                                            Years after Gastrectomies                                                                                                                                               Years after Gastrectomies




METHODS: In trial (1975-2011) the data of consecutive 612 GCP after
radical surgery (age=56.6±9.4 years; m=422, f=190; tumor
diameter=5.7±3.0 cm; distal GE=364, proximal=132, total=116, D2-
lymphadenectomy=381, D3-4=231; combined procedures=209; T1=168,
T2=182, T3=127, T4=135; N0=303, N1=84, N2=225; G1=175, G2=104,
G3=333) was reviewed. Cox regression, clustering, SEPATH, Monte
Carlo, bootstrap, neural network simulation were used to determine any
significant regularity.




                                         Poster number                                                                                 Track                                                                              Disclosure of Interest:
                                         EP144                                                                                         2012WCC-1864                                                                       Declared
5-YEAR SURVIVAL OF GASTRIC CANCER
PATIENTS AFTER COMPLETE
GASTRECTOMIES SIGNIFICANTLY
DEPENDED ON PHASE TRANSITION
“EARLY-INVASIVE CANCER”, LYMPH NODE
METASTASES AND CELL RATIO FACTORS

Oleg Kshivets
RESULTS: Overall life span (LS) was 2015.5±2208.5 days and
cumulative 5-year survival (5YS) reached 50.9%, 10 years – 44.2%, 20
years – 32.6%. 222 GCP lived more than 5 years without GC. 271 GCP
died because of GC. Cox modeling displayed that 5YS significantly
depended on: phase transition (PT) early-invasive GC in terms of
synergetics, PT N0-N12, cell ratio factors (CRF) (ratio between cancer
cells – CC and blood cells subpopulations) (P=0.000-0.047). Neural
networks, genetic algorithm selection and bootstrap simulation revealed
relationships between 5YS and PT early-invasive GC (rank=1), PT N0-
N12 (rank=2), healthy cells/CC, erythrocytes/CC, lymphocytes/CC,
monocytes/CC, leucocytes/CC, stab neutrophils/CC, eosinophils/CC,
segmented neutrophils/CC, thrombocytes/CC. Correct prediction of 5YS
was 100% by neural networks computing.




 CONCLUSIONS: 5-year survival of gastric cancer patients after radical
gastrectomies significantly depended on:
1)Phase transition “early-invasive cancer”;
2)Phase transition N0-N12;
3)Cell Ratio Factors.
   Poster number         Track                    Disclosure of Interest:
   EP144                 2012WCC-1864             Declared

Contenu connexe

En vedette

Surgical complications of Gastrectomy
Surgical complications of GastrectomySurgical complications of Gastrectomy
Surgical complications of GastrectomyBala Sankar
 
Cancergastri2008
Cancergastri2008Cancergastri2008
Cancergastri2008Deep Deep
 
Gastric cancer presentation final
Gastric cancer presentation finalGastric cancer presentation final
Gastric cancer presentation finalTamer Madi
 
gastric resection, reconstruction and post gastrectomy syndromes
gastric resection, reconstruction and post gastrectomy syndromesgastric resection, reconstruction and post gastrectomy syndromes
gastric resection, reconstruction and post gastrectomy syndromessanyal1981
 

En vedette (9)

Surgical complications of Gastrectomy
Surgical complications of GastrectomySurgical complications of Gastrectomy
Surgical complications of Gastrectomy
 
Cancergastri2008
Cancergastri2008Cancergastri2008
Cancergastri2008
 
Gastric cancer
Gastric cancerGastric cancer
Gastric cancer
 
Gastric Cancer PPT
Gastric Cancer PPTGastric Cancer PPT
Gastric Cancer PPT
 
Carcinoma stomach
Carcinoma stomachCarcinoma stomach
Carcinoma stomach
 
Carcinoma of Stomach
 Carcinoma of Stomach Carcinoma of Stomach
Carcinoma of Stomach
 
Gastric cancer presentation final
Gastric cancer presentation finalGastric cancer presentation final
Gastric cancer presentation final
 
Gastric cancer
Gastric cancerGastric cancer
Gastric cancer
 
gastric resection, reconstruction and post gastrectomy syndromes
gastric resection, reconstruction and post gastrectomy syndromesgastric resection, reconstruction and post gastrectomy syndromes
gastric resection, reconstruction and post gastrectomy syndromes
 

Plus de Oleg Kshivets

Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...
Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...
Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...Oleg Kshivets
 
Esophageal Cancer: Artificial Intelligence, Synergetics, Complex System Analy...
Esophageal Cancer: Artificial Intelligence, Synergetics, Complex System Analy...Esophageal Cancer: Artificial Intelligence, Synergetics, Complex System Analy...
Esophageal Cancer: Artificial Intelligence, Synergetics, Complex System Analy...Oleg Kshivets
 
Kshivets Oleg Optimization of Management for Esophageal Cancer Patients (T1-...
Kshivets Oleg  Optimization of Management for Esophageal Cancer Patients (T1-...Kshivets Oleg  Optimization of Management for Esophageal Cancer Patients (T1-...
Kshivets Oleg Optimization of Management for Esophageal Cancer Patients (T1-...Oleg Kshivets
 
Kshivets_IASLC_Singapore2023.pdf
Kshivets_IASLC_Singapore2023.pdfKshivets_IASLC_Singapore2023.pdf
Kshivets_IASLC_Singapore2023.pdfOleg Kshivets
 
KshivetsWSCTS2023_Brazil.pdf
KshivetsWSCTS2023_Brazil.pdfKshivetsWSCTS2023_Brazil.pdf
KshivetsWSCTS2023_Brazil.pdfOleg Kshivets
 
KshivetsWSCTS2023_Brazil.pdf
KshivetsWSCTS2023_Brazil.pdfKshivetsWSCTS2023_Brazil.pdf
KshivetsWSCTS2023_Brazil.pdfOleg Kshivets
 
KshivetsWSCTS2023_Brazil.pdf
KshivetsWSCTS2023_Brazil.pdfKshivetsWSCTS2023_Brazil.pdf
KshivetsWSCTS2023_Brazil.pdfOleg Kshivets
 
Kshivets_WCGIC2023.pdf
Kshivets_WCGIC2023.pdfKshivets_WCGIC2023.pdf
Kshivets_WCGIC2023.pdfOleg Kshivets
 
Kshivets_ELCC2023.pdf
Kshivets_ELCC2023.pdfKshivets_ELCC2023.pdf
Kshivets_ELCC2023.pdfOleg Kshivets
 
Kshivets_ELCC2023.pdf
Kshivets_ELCC2023.pdfKshivets_ELCC2023.pdf
Kshivets_ELCC2023.pdfOleg Kshivets
 
Lung Cancer: Precise Prediction
Lung Cancer: Precise PredictionLung Cancer: Precise Prediction
Lung Cancer: Precise PredictionOleg Kshivets
 
Kshivets_SPB_WSCTS2022Eso.pdf
Kshivets_SPB_WSCTS2022Eso.pdfKshivets_SPB_WSCTS2022Eso.pdf
Kshivets_SPB_WSCTS2022Eso.pdfOleg Kshivets
 
Kshivets_SPB_WSCTS2022Lung.pdf
Kshivets_SPB_WSCTS2022Lung.pdfKshivets_SPB_WSCTS2022Lung.pdf
Kshivets_SPB_WSCTS2022Lung.pdfOleg Kshivets
 
Lung cancer cell dynamics significantly depended on blood cell circuit, bioch...
Lung cancer cell dynamics significantly depended on blood cell circuit, bioch...Lung cancer cell dynamics significantly depended on blood cell circuit, bioch...
Lung cancer cell dynamics significantly depended on blood cell circuit, bioch...Oleg Kshivets
 
Esophageal Cancer: Precise Prediction
Esophageal Cancer: Precise Prediction      Esophageal Cancer: Precise Prediction
Esophageal Cancer: Precise Prediction Oleg Kshivets
 
Survival of Lung Cancer Patients after Lobectomies was Significantly Superior...
Survival of Lung Cancer Patients after Lobectomies was Significantly Superior...Survival of Lung Cancer Patients after Lobectomies was Significantly Superior...
Survival of Lung Cancer Patients after Lobectomies was Significantly Superior...Oleg Kshivets
 
• Gastric cancer prognosis and cell ratio factors
•	Gastric cancer prognosis and cell ratio factors           •	Gastric cancer prognosis and cell ratio factors
• Gastric cancer prognosis and cell ratio factors Oleg Kshivets
 
Kshivets gc 10_ys_wjarr-2021-0659
Kshivets gc 10_ys_wjarr-2021-0659Kshivets gc 10_ys_wjarr-2021-0659
Kshivets gc 10_ys_wjarr-2021-0659Oleg Kshivets
 
Kshivets lc10 ys_wjarr
Kshivets lc10 ys_wjarrKshivets lc10 ys_wjarr
Kshivets lc10 ys_wjarrOleg Kshivets
 

Plus de Oleg Kshivets (20)

Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...
Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...
Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...
 
Esophageal Cancer: Artificial Intelligence, Synergetics, Complex System Analy...
Esophageal Cancer: Artificial Intelligence, Synergetics, Complex System Analy...Esophageal Cancer: Artificial Intelligence, Synergetics, Complex System Analy...
Esophageal Cancer: Artificial Intelligence, Synergetics, Complex System Analy...
 
Kshivets Oleg Optimization of Management for Esophageal Cancer Patients (T1-...
Kshivets Oleg  Optimization of Management for Esophageal Cancer Patients (T1-...Kshivets Oleg  Optimization of Management for Esophageal Cancer Patients (T1-...
Kshivets Oleg Optimization of Management for Esophageal Cancer Patients (T1-...
 
Kshivets_IASLC_Singapore2023.pdf
Kshivets_IASLC_Singapore2023.pdfKshivets_IASLC_Singapore2023.pdf
Kshivets_IASLC_Singapore2023.pdf
 
KshivetsWSCTS2023_Brazil.pdf
KshivetsWSCTS2023_Brazil.pdfKshivetsWSCTS2023_Brazil.pdf
KshivetsWSCTS2023_Brazil.pdf
 
KshivetsWSCTS2023_Brazil.pdf
KshivetsWSCTS2023_Brazil.pdfKshivetsWSCTS2023_Brazil.pdf
KshivetsWSCTS2023_Brazil.pdf
 
KshivetsWSCTS2023_Brazil.pdf
KshivetsWSCTS2023_Brazil.pdfKshivetsWSCTS2023_Brazil.pdf
KshivetsWSCTS2023_Brazil.pdf
 
Kshivets_WCGIC2023.pdf
Kshivets_WCGIC2023.pdfKshivets_WCGIC2023.pdf
Kshivets_WCGIC2023.pdf
 
Kshivets_ELCC2023.pdf
Kshivets_ELCC2023.pdfKshivets_ELCC2023.pdf
Kshivets_ELCC2023.pdf
 
Kshivets_ELCC2023.pdf
Kshivets_ELCC2023.pdfKshivets_ELCC2023.pdf
Kshivets_ELCC2023.pdf
 
Lung Cancer: Precise Prediction
Lung Cancer: Precise PredictionLung Cancer: Precise Prediction
Lung Cancer: Precise Prediction
 
Kshivets_SPB_WSCTS2022Eso.pdf
Kshivets_SPB_WSCTS2022Eso.pdfKshivets_SPB_WSCTS2022Eso.pdf
Kshivets_SPB_WSCTS2022Eso.pdf
 
Kshivets_SPB_WSCTS2022Lung.pdf
Kshivets_SPB_WSCTS2022Lung.pdfKshivets_SPB_WSCTS2022Lung.pdf
Kshivets_SPB_WSCTS2022Lung.pdf
 
Lung cancer cell dynamics significantly depended on blood cell circuit, bioch...
Lung cancer cell dynamics significantly depended on blood cell circuit, bioch...Lung cancer cell dynamics significantly depended on blood cell circuit, bioch...
Lung cancer cell dynamics significantly depended on blood cell circuit, bioch...
 
Esophageal Cancer: Precise Prediction
Esophageal Cancer: Precise Prediction      Esophageal Cancer: Precise Prediction
Esophageal Cancer: Precise Prediction
 
Survival of Lung Cancer Patients after Lobectomies was Significantly Superior...
Survival of Lung Cancer Patients after Lobectomies was Significantly Superior...Survival of Lung Cancer Patients after Lobectomies was Significantly Superior...
Survival of Lung Cancer Patients after Lobectomies was Significantly Superior...
 
• Gastric cancer prognosis and cell ratio factors
•	Gastric cancer prognosis and cell ratio factors           •	Gastric cancer prognosis and cell ratio factors
• Gastric cancer prognosis and cell ratio factors
 
Kshivets elcc2022
Kshivets elcc2022Kshivets elcc2022
Kshivets elcc2022
 
Kshivets gc 10_ys_wjarr-2021-0659
Kshivets gc 10_ys_wjarr-2021-0659Kshivets gc 10_ys_wjarr-2021-0659
Kshivets gc 10_ys_wjarr-2021-0659
 
Kshivets lc10 ys_wjarr
Kshivets lc10 ys_wjarrKshivets lc10 ys_wjarr
Kshivets lc10 ys_wjarr
 

Dernier

History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdfDolisha Warbi
 
See the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy PlatformSee the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy PlatformKweku Zurek
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfDolisha Warbi
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptxTina Purnat
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!ibtesaam huma
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptxDr.Nusrat Tariq
 
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...saminamagar
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsMedicoseAcademics
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxDr. Dheeraj Kumar
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxdrashraf369
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptxMohamed Rizk Khodair
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?bkling
 

Dernier (20)

History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
 
See the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy PlatformSee the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy Platform
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptx
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!
 
Epilepsy
EpilepsyEpilepsy
Epilepsy
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptx
 
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes Functions
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptx
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptx
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?
 

Kshivets O. Gastric Cancer Surgery

  • 1. 5-YEAR SURVIVAL OF GASTRIC CANCER PATIENTS AFTER COMPLETE GASTRECTOMIES SIGNIFICANTLY DEPENDED ON PHASE TRANSITION “EARLY- INVASIVE CANCER”, LYMPH NODE METASTASES AND CELL RATIO FACTORS Oleg Kshivets EP144 2012 WCC-1864
  • 2. 5-YEAR SURVIVAL OF GASTRIC CANCER PATIENTS AFTER COMPLETE GASTRECTOMIES SIGNIFICANTLY DEPENDED ON PHASE TRANSITION “EARLY-INVASIVE CANCER”, LYMPH NODE METASTASES AND CELL RATIO FACTORS Oleg Kshivets OBJECTIVE: We examined prognostic factors of gastric cancer (GC) patients (GCP) (T1-4N0-2M0) after complete (R0) gastrectomies (GE). Cox Regression: Variables in the Equation Chi2=74.35; df=5; P=0.00000; B SE Wald df Sig. Exp(B) PT E-I Cancer -,340 ,169 4,047 1 ,044 ,712 PT N0-N12 -,272 ,046 35,091 1 ,000 ,762 Monocytes/CC ,384 ,193 3,947 1 ,047 1,468 Lymphocytes/CC -,098 ,046 4,527 1 ,033 ,906 Erythrocytes/CC ,013 ,021 ,385 1 ,535 1,013 Cumulative Proportion Surviving (Kaplan-Meier) Cumulative Proportion Surviving (Kaplan-Meier) Complete Censored Complete Censored P=0.000 by Log-Rank Test P=0.000 by Log-Rank Test 1.0 1.0 0.9 0.9 GCP with N1-2, n=309 GCP with N0, n=303 Cumulative Proportion Surviving Cumulative Proportion Surviving 0.8 0.8 0.7 0.7 0.6 0.6 0.5 0.5 Invasive GCP, n=515 0.4 Early GCP, n=97 0.4 0.3 0.3 0.2 0.2 0.1 0.1 0.0 0.0 0 5 10 15 20 25 30 35 40 0 5 10 15 20 25 30 35 40 Years after Gastrectomies Years after Gastrectomies METHODS: In trial (1975-2011) the data of consecutive 612 GCP after radical surgery (age=56.6±9.4 years; m=422, f=190; tumor diameter=5.7±3.0 cm; distal GE=364, proximal=132, total=116, D2- lymphadenectomy=381, D3-4=231; combined procedures=209; T1=168, T2=182, T3=127, T4=135; N0=303, N1=84, N2=225; G1=175, G2=104, G3=333) was reviewed. Cox regression, clustering, SEPATH, Monte Carlo, bootstrap, neural network simulation were used to determine any significant regularity. Poster number Track Disclosure of Interest: EP144 2012WCC-1864 Declared
  • 3. 5-YEAR SURVIVAL OF GASTRIC CANCER PATIENTS AFTER COMPLETE GASTRECTOMIES SIGNIFICANTLY DEPENDED ON PHASE TRANSITION “EARLY-INVASIVE CANCER”, LYMPH NODE METASTASES AND CELL RATIO FACTORS Oleg Kshivets RESULTS: Overall life span (LS) was 2015.5±2208.5 days and cumulative 5-year survival (5YS) reached 50.9%, 10 years – 44.2%, 20 years – 32.6%. 222 GCP lived more than 5 years without GC. 271 GCP died because of GC. Cox modeling displayed that 5YS significantly depended on: phase transition (PT) early-invasive GC in terms of synergetics, PT N0-N12, cell ratio factors (CRF) (ratio between cancer cells – CC and blood cells subpopulations) (P=0.000-0.047). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive GC (rank=1), PT N0- N12 (rank=2), healthy cells/CC, erythrocytes/CC, lymphocytes/CC, monocytes/CC, leucocytes/CC, stab neutrophils/CC, eosinophils/CC, segmented neutrophils/CC, thrombocytes/CC. Correct prediction of 5YS was 100% by neural networks computing. CONCLUSIONS: 5-year survival of gastric cancer patients after radical gastrectomies significantly depended on: 1)Phase transition “early-invasive cancer”; 2)Phase transition N0-N12; 3)Cell Ratio Factors. Poster number Track Disclosure of Interest: EP144 2012WCC-1864 Declared